Late-Stage Clinical Study Readouts Biotech Investors Should Watch

Late-Stage Clinical Study Readouts Biotech Investors Should Watch

Source: 
Motley Fool
snippet: 

Clinical updates can provide major catalysts for pharmaceutical and biotech stocks. In this Motley Fool Live video recorded on June 30, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss some late-stage clinical readouts on the way this year that investors should closely watch.